Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy

October 27, 2025 updated by: Mayo Clinic

Acupressure for Anxiety: A Pilot Study of a Nurse-Led Acupressure Intervention for Patients Receiving Chemotherapy

This clinical trial evaluates whether acupressure is helpful to reduce anxiety related to chemotherapy. Anxiety is experienced by many patients with cancer. Anxiety can be related to chemotherapy and may contribute to other symptoms, such as nausea and poor quality of life. Some patients diagnosed with cancer express interest in non-medicinal ways to manage symptoms. Acupressure is a noninvasive intervention that can be used for many different symptoms. Acupressure is well tolerated with minimal reports of adverse reactions, making it a good choice for patients with cancer. This study may help researchers learn whether acupressure is useful for managing anxiety in patients undergoing chemotherapy.

Study Overview

Detailed Description

PRIMARY OBJECTIVES:

I. Evaluate the feasibility of a nurse- and patient-applied acupressure intervention for patients with anxiety associated with active cancer-directed therapy.

II. Patient-reported changes in acute anxiety associated with both the nurse and self-led acupressure interventions will be ascertained.

OUTLINE:

Patients undergo acupressure over 15-120 seconds at a time for up to 15 minutes. After completion of the session, patients may optionally receive an education session on using acupressure at home.

After completion of study intervention, patients who opted to receive education about using acupressure at home are followed up at 1 week.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic in Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Be over 18 years of age
  • Be actively undergoing chemotherapy in the Mayo Clinic chemotherapy unit
  • Report anxiety as a 1 or higher, on a scale from 0 (no anxiety) to 4 (severe anxiety)
  • Be willing to undergo a short acupressure session

Exclusion Criteria:

  • Does not meet the inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Supportive Care (acupressure)
Patients undergo acupressure over 15-120 seconds at a time for up to 15 minutes. After completion of the session, patients may optionally receive an education session on using acupressure at home.
Ancillary studies
Ancillary studies
Undergo acupressure
Other Names:
  • Acupressure
  • Ischemic Compression
Receive education session about using acupressure at home
Other Names:
  • Education for Intervention
  • Intervention by Education
  • Intervention through Education
  • Intervention, Educational

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients approached about undergoing acupressure intervention (Feasibility)
Time Frame: Up to 1 year
Assessed by the number of patients approached about undergoing acupressure intervention.
Up to 1 year
Number of patients interested in the initial acupressure intervention in the chemotherapy unit (Feasibility)
Time Frame: Up to 1 year
Assessed by the number of patients who express interest in the initial acupressure intervention in the chemotherapy unit.
Up to 1 year
Number of patients interested in the home acupressure intervention (Feasibility)
Time Frame: Up to 1 year
Assessed by the number of patients who express interest in the home acupressure intervention.
Up to 1 year
Time taken for each nurse-led acupressure intervention in the chemotherapy unit (Feasibility)
Time Frame: Up to 1 year
Assess by the time recorded for ach nurse-led acupressure intervention in the chemotherapy unit.
Up to 1 year
Patient-reported changes in acute anxiety
Time Frame: At baseline, after a one-time nurse-administered acupressure session, and after one week of self-administered acupressure sessions
Assessed with a brief anxiety questionnaire that inquires about the three different domains of anxiety: cognitive symptoms, emotional symptoms, and physical symptoms. Seven questions are answered using 11-point (0-10) scales with different values assigned to the scale per question (e.g. 0=no anxiety/10=worst possible anxiety or 0=strongly disagree/10=strongly agree).
At baseline, after a one-time nurse-administered acupressure session, and after one week of self-administered acupressure sessions

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Laura S. Rhee, D.O., Mayo Clinic in Rochester

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 8, 2023

Primary Completion (Actual)

January 29, 2024

Study Completion (Actual)

February 1, 2024

Study Registration Dates

First Submitted

March 14, 2024

First Submitted That Met QC Criteria

March 14, 2024

First Posted (Actual)

March 21, 2024

Study Record Updates

Last Update Posted (Estimated)

October 29, 2025

Last Update Submitted That Met QC Criteria

October 27, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • MC221001 (Other Identifier: Mayo Clinic in Rochester)
  • NCI-2024-00538 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
  • 23-004067 (Other Identifier: Mayo Clinic Institutional Review Board)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malignant Solid Neoplasm

Clinical Trials on Questionnaire Administration

Subscribe